Paper

Table S2 from Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL

2026 · Yi‐Jiun Su, Anne Marijn Kramer, Mark P. Hamilton et al.